Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN03110798Phase 4Completed
Phase 4, randomised trial in Postoperative ocular inflammation and cataract comparing Indomethacin 0.1% eyedrops with Ketorolac 0.5% eyedrops (2 arms). Primary endpoint: Aqueous flare at Day 1 and Day 7. Started Apr 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN03110798.